Visualizar por autor "Sánchez Barceló, Emilio José"

Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome

Parisotto, Eduardo B.; Vidal Sánchez, Verónica

; García Cerro, Susana

; Lantigua Romero, Sara

; Filho, Danilo Wilhelm; Sánchez Barceló, Emilio José

; Martínez-Cué, Carmen

; Rueda Revilla, Noemí

(Springer, 2016)

Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome

Corrales Pardo, Andrea

; Vidal Casado, Rebeca; García Cerro, Susana

; Vidal Sánchez, Verónica

; Martínez Fernández, Paula

; García Iglesias, María Eva

; Florez Beledo, Jesús; Sánchez Barceló, Emilio José

; Martínez-Cué, Carmen

; Rueda Revilla, Noemí

(Blackwell Publishing Ltd, 2014)

Clinical uses of melatonin in pediatrics

Sánchez Barceló, Emilio José

; Mediavilla Aguado, María Dolores

; Reiter, Russel J. (John Wiley & Sons, 2011)

Inhibitory effects of melatonin on sulfatase and 17ß-hydroxysteroid dehydrogenase activity and expression in glioma cells

González Cabeza, Alicia Verónica

; Martínez Campa, Carlos Manuel

; Mediavilla Aguado, María Dolores

; Alonso González, Carolina

; Alvarez García, Virginia; Sánchez Barceló, Emilio José

; Cos Corral, Samuel

(Spandidos Publications, 2010)

Melatonin: A Molecule for Reducing Breast Cancer Risk

González González, Alicia; Mediavilla Aguado, María Dolores

; Sánchez Barceló, Emilio José

(MDPI, 2018)

Nuevos enfoques al problema de la obesidad. Papel de la cronodisrupción

Barbero Santillán, Nuria (2016-06-01)

Posibles efectos de la exposición nocturna a la luz, sobre la carcinogénesis humana

Arroyo Huidobro, Marta (2016-06-01)

Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndrome

Corrales Pardo, Andrea

; Parisotto, Eduardo B.; Vidal Sánchez, Verónica

; García Cerro, Susana

; Lantigua Romero, Sara

; Diego, Marian; Filho, Danilo Wilhem; Sánchez Barceló, Emilio José

; Martínez-Cué, Carmen

; Rueda Revilla, Noemí

(Elsevier, 2017)

¿Qué es la optogenética? Aplicaciones futuras a la práctica clínica

Barrientos Duque, Marta A. (2016-06-07)

Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin

Carpizo Alfayate, Rosario; Martínez, Ángeles; Mediavilla Aguado, María Dolores

; González Martínez, Mónica

; Abad, Araceli; Sánchez Barceló, Emilio José

(Mosby, 2006)

Técnicas terapéuticas basadas en la utilización de luz visible

Cossío Tejido, Santiago de (2015-06-12)

Visualizar por autor "Sánchez Barceló, Emilio José"

Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome

Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome

Clinical uses of melatonin in pediatrics

Inhibitory effects of melatonin on sulfatase and 17ß-hydroxysteroid dehydrogenase activity and expression in glioma cells

Melatonin: A Molecule for Reducing Breast Cancer Risk

Nuevos enfoques al problema de la obesidad. Papel de la cronodisrupción

Posibles efectos de la exposición nocturna a la luz, sobre la carcinogénesis humana

Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndrome

¿Qué es la optogenética? Aplicaciones futuras a la práctica clínica

Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin

Técnicas terapéuticas basadas en la utilización de luz visible

Listar

Mi cuenta

Sobre UCrea

Piensa en abierto

Compartir

Visualizar por autor "Sánchez Barceló, Emilio José"

Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome ﻿

Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome ﻿

Clinical uses of melatonin in pediatrics ﻿

Inhibitory effects of melatonin on sulfatase and 17ß-hydroxysteroid dehydrogenase activity and expression in glioma cells ﻿

Melatonin: A Molecule for Reducing Breast Cancer Risk ﻿

Nuevos enfoques al problema de la obesidad. Papel de la cronodisrupción ﻿

Posibles efectos de la exposición nocturna a la luz, sobre la carcinogénesis humana ﻿

Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndrome ﻿

¿Qué es la optogenética? Aplicaciones futuras a la práctica clínica ﻿

Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin ﻿

Técnicas terapéuticas basadas en la utilización de luz visible ﻿

Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome

Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome

Clinical uses of melatonin in pediatrics

Inhibitory effects of melatonin on sulfatase and 17ß-hydroxysteroid dehydrogenase activity and expression in glioma cells

Melatonin: A Molecule for Reducing Breast Cancer Risk

Nuevos enfoques al problema de la obesidad. Papel de la cronodisrupción

Posibles efectos de la exposición nocturna a la luz, sobre la carcinogénesis humana

Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndrome

¿Qué es la optogenética? Aplicaciones futuras a la práctica clínica

Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin

Técnicas terapéuticas basadas en la utilización de luz visible